Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

AKER

Akers Biosciences (AKER)

Akers Biosciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:AKER
日付受信時刻ニュースソース見出しコード企業名
2020/09/1207 : 22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AKERAkers Biosciences Inc
2020/09/1206 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/09/1005 : 56Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:AKERAkers Biosciences Inc
2020/09/0906 : 31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AKERAkers Biosciences Inc
2020/09/0205 : 35Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AKERAkers Biosciences Inc
2020/09/0102 : 13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AKERAkers Biosciences Inc
2020/08/2906 : 04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/08/2722 : 00GlobeNewswire Inc.Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept ResultsNASDAQ:AKERAkers Biosciences Inc
2020/08/2620 : 04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AKERAkers Biosciences Inc
2020/08/1820 : 19Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AKERAkers Biosciences Inc
2020/08/1321 : 41Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AKERAkers Biosciences Inc
2020/08/1121 : 00GlobeNewswire Inc.Akers Biosciences Announces $6.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:AKERAkers Biosciences Inc
2020/07/2719 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/07/2405 : 29Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:AKERAkers Biosciences Inc
2020/07/2306 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/07/1406 : 11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AKERAkers Biosciences Inc
2020/07/1321 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/07/0900 : 49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/07/0722 : 00GlobeNewswire Inc.Akers Biosciences and Premas Biotech Announce Initiation of Animal StudiesNASDAQ:AKERAkers Biosciences Inc
2020/06/1519 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AKERAkers Biosciences Inc
2020/06/0605 : 41Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:AKERAkers Biosciences Inc
2020/05/2619 : 23Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AKERAkers Biosciences Inc
2020/05/2306 : 02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AKERAkers Biosciences Inc
2020/05/2204 : 02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:AKERAkers Biosciences Inc
2020/05/1919 : 02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/05/1906 : 33GlobeNewswire Inc.Akers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesNASDAQ:AKERAkers Biosciences Inc
2020/05/1819 : 14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
2020/05/1819 : 08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AKERAkers Biosciences Inc
2020/05/1605 : 12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AKERAkers Biosciences Inc
2020/05/1521 : 18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:AKER